New Key Statistics Module, Z-Score and F-Score
NAS:ALGS Key Ratios
| Market Cap $ M | 41.53 |
| Enterprise Value $ M | 14.65 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.30 |
| Price/Sales | 2.22 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 31.00 |
| EPS (TTM) $ | -7.30 |
| Beneish M-Score | 6.75 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 47.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.19 |
| EV-to-EBITDA | -0.19 |
| PEG | -- |
| Shares Outstanding M | 6.24 |
| Net Margin (%) | -241.01 |
| Operating Margin % | -250.63 |
| Pre-tax Margin (%) | -230.81 |
| Quick Ratio | 2.19 |
| Current Ratio | 2.19 |
| ROA % (ttm) | -81.88 |
| ROE % (ttm) | -130.56 |
| ROIC % (ttm) | -520.38 |
| Dividend Yield % | -- |
| Altman Z-Score | -15.87 |
ALGS Number of Guru Trades
ALGS Volume of Guru Trades
Gurus Latest Trades with NAS:ALGS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALGS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aligos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ALGS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers